Bibliographic Details
| Title: |
Unraveling Cannabidiol's Dual Modulatory Role in Schizophrenia:Network Pharmacology and in Vivo Validation of Neuroinflammatory and Behavioral Modulation |
| Authors: |
By:Ying Wei, Xue Mei, Xiang Liu, Rongchuan Su, Zhi We |
| Source: |
SSRN Cannabis Preprints (USA), January 31, 2025 Cannabis, 2pp |
| Abstract: |
Schizophrenia is a chronic psychiatric disorder manifests with symptoms such as cognitive impairment, hallucinations, and delusions. Currently available antipsychotic medications offer limited effectiveness and commonly induce side effects like extrapyramidal symptoms, metabolic and cardiovascular complications. Cannabidiol (CBD), derived from Cannabis sativa, has shown promise in treating neurological and psychiatric disorders, but the precise mechanisms of CBD in mitigating schizophrenia symptoms remain elusive... |
| Database: |
NewsBank |
